Ipamorelin Protocol
Dosing & Research
Last Updated: September 4, 2026
- Amino Acid Sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Molecular Formula
- C38H49N9O5
- Molecular Weight
- 711.86 g/mol
- CAS Number
- 170851-70-4
Selective GH release research, Sleep/recovery studies, IGF-1 modulation, Combination peptide protocols
How It Works
- Selective GH release research
- Sleep/recovery studies
- IGF-1 modulation
- Combination peptide protocols
Dosing Structure
Example Protocols
Find Research Grade Ipamorelin
Recommended vendors for sourcing research-grade material. PeptaBase does not sell peptides directly.
Vendor One Research Labs
COA VerifiedThird-party COA-verified research peptides with published batch testing.
Source Coming SoonVendor Two Sciences
Purity TestedUS-based research compound supplier with independent purity testing.
Source Coming SoonVendor Three Peptide Co.
Bulk research peptide sourcing with batch-level documentation.
Source Coming SoonProtocol Notes
What Is Ipamorelin?
Ipamorelin is a selective growth hormone releasing peptide (GHRP) that triggers GH pulses from the pituitary gland with minimal effect on cortisol or prolactin - a key advantage over older GHRPs. It is studied as a model compound for GH deficiency research, recovery enhancement, and body composition improvement without the off-target hormonal activity seen with GHRP-2 or GHRP-6.
- ▸Human dose-response study: 200 mcg intravenous ipamorelin produced a mean peak GH of ~20 ng/mL within 30 minutes in healthy adults; cortisol and prolactin were not significantly elevated (PMID: 9849822).
- ▸Compared to GHRP-6, ipamorelin produced equivalent GH release at similar doses with no significant cortisol stimulation - making it more selective (Raun et al., 1998).
- ▸Rat chronic administration study: 12-week subcutaneous ipamorelin in old rats increased IGF-1 levels and lean body mass vs. saline controls.
- ▸Bone density: Ipamorelin administration in ovariectomized rats increased cortical and cancellous bone mineral density - proposed mechanism involves IGF-1 upregulation.
- ▸No large-scale human clinical trials for anti-aging or body composition outcomes have been published.
Evidence Summary
Commonly Researched With
Research & Studies
- Curated References
- CuratedPubMedPMID 9849822Ipamorelin, the first selective growth hormone secretagogue↗Eur J Endocrinol · 1998 · Raun K, Hansen BS, Johansen NL, et al.dosingmechanismhumanselectivity
- CuratedPubMedPMID 10401584Ipamorelin stimulates body weight gain in lean and obese Zucker rats↗Eur J Endocrinol · 1999 · Hansen BS, Raun K, Nielsen KK, et al.dosinganimalbody composition
Research Feedback
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.